Respiratory Syncytial Virus Diagnostic Testing MarketPosted by Devanand on May 21st, 2021 Respiratory syncytial virus (RSV) causes infection of respiratory system (lungs and breathing passage). It may also affect heart and immune system resulting in more serious illnesses (e.g. tachypnea, cyanosis).Premature infants (30-40 days) and children (less than 2 year of age) are at the highest risk of this infection. According to the U.S. Centre for Disease Control and Prevention (CDC), RSV is the common cause of bronchiolitis or pneumonia in the children under one year of age in the United States. Each year 75,000 to 125,000 children are hospitalized due to RSV infections. This Infection can result from the direct (i.e. kiss, touch or shake hands with infected person) or indirect contact (i.e. contact with sneeze, cough or blows of infected person)with the infected person. Mild headache, runny nose, cough and sore throat are some of the common symptoms of RSV viral infections. Diagnosis of these infections is facilitated by specific tests like polymerase chain reaction assay, molecular probes, chest radiography. Physicians also administer intubation (breathing tube), mechanical ventilation or some antibiotics (like palivizumab) in order to treat the patients with RSV infections. Read Report Overview - https://www.transparencymarketresearch.com/respiratory-syncytial-virus-diagnostic-testing.html Increasing incidences of childhood pneumonia, acts as one of the major factors to drive the growth of RSV diagnostic testing market. According to the data enumerated by World Health Organization (WHO), in 2010, approximately 1.1 million people in the United States were hospitalized with pneumonia and 50,000 people died from this disease. In addition, crowded population and unhygienic environment (dirty premises, unhygienic eating places) may increase the chances of RSV infection thereby resulting in increased need and demand for effective RSV diagnostic tests. However, high number of other pathogens that may cause similar symptoms of respiratory illness and lack of availability of specific treatment options to curb this infection may restrain the growth of this market. Request Brochure – https://www.transparencymarketresearch.com/sample/sample.php?flag=B&rep_id=2065 The global Respiratory Syncytial Virus Diagnostic Testing Market can be segmented as follows:
o Molecular Diagnostics o Immunoassays o Monoclonal Antibodies o Flow Cytometry o Diagnostic Imaging o Chromatography o Gel Microdroplets o Others
o Physician offices or group practices o Hospitals o Commercial Laboratories o Nursing Homes Geographically, North America and Europe dominate the global RSV diagnostic testing market due to increasing patient population suffering from respiratory syncytial virus. According to the U.S. CDC, approximately 50,000 deaths are noted due to pneumonia in the United States in year of 2012.In addition, Asia-Pacific countries such as India and China, South East Asian countries are the emerging regions for global RSV diagnostic testing market due to high prevalence of these diseases (i.e. pneumonia, bronchitis) in these regions and increasing healthcare awareness. Some of the key players in this industry are Abbott Laboratories, Beckman Coulter, Ortho-Clinical Diagnostics, bioMerieux, F. Hoffman-La Roche, Ltd., Bio-Rad Laboratories, Inc., DiaSorin S.p.A , Novartis Diagnostics, Becton Dickson company and Thermo Fisher Scientific among others. This study by TMR is all-encompassing framework of the dynamics of the market. It mainly comprises critical assessment of consumers' or customers' journeys, current and emerging avenues, and strategic framework to enable CXOs take effective decisions. Our key underpinning is the 4-Quadrant Framework EIRS that offers detailed visualization of four elements:
The study strives to evaluate the current and future growth prospects, untapped avenues, factors shaping their revenue potential, and demand and consumption patterns in the global market by breaking it into region-wise assessment. The following regional segments are covered comprehensively:
The EIRS quadrant framework in the report sums up our wide spectrum of data-driven research and advisory for CXOs to help them make better decisions for their businesses and stay as leaders.
Like it? Share it! More by this author |